Transforming growth factor-β (TGF-β)-inducible gene TMEPAI converts TGF-β from a tumor suppressor to a tumor promoter in breast cancer

Cancer Research

Volumn 70, Issue 15, 2010, Pages 6377-6383

  Singha, Prajjal K ^a   Yeh, I Tien ^a   Venkatachalam, Manjeri A ^a   Saikumar, Pothana ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN TMEPAI; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPLICATION; ENZYME PHOSPHORYLATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TMEPAI GENE; TUMOR PROMOTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL GROWTH PROCESSES; CELL MOVEMENT; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; MICE; MICE, NUDE; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 77955401078     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1180     Document Type: Article

References (20)

1. Tanner MM, Tirkkonen M, Kallioniemi A, et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 1994;54:4257-60.
2. Courjal F, Cuny M, Rodriguez C, et al. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br J Cancer 1996;74:1984-9.
3. Cuthill S, Agarwal P, Sarkar S, Savelieva E, Reznikoff CA. Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 1999;26:304-11.
4. Tremain R, Marko M, Kinnimulki V, Ueno H, Bottinger E, Glick A. Defects in TGF-β signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Oncogene 2000;19:1698-709.
5. Padua D, Massague J. Roles of TGF-β in metastasis. Cell Res 2009;19:89-102.
6. Jakowlew SB. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev 2006;25:435-57.
7. Brunschwig EB, Wilson K, Mack D, et al. PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res 2003;63:1568-75.
8. Xu LL, Shanmugam N, Segawa T, et al. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics 2000;66:257-63.
9. Xu LL, Shi Y, Petrovics G, et al. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res 2003;63:4299-304.
10. Giannini G, Ambrosini MI, Di Marcotullio L, et al. EGF- and cell-cycleregulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer. Mol Carcinog 2003;38:188-200.
11. Hirokawa YS, Takagi A, Uchida K, et al. High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone:. Cell Mol Biol Lett 2007;12:370-7.
12. Rae FK, Hooper JD, Nicol DL, Clements JA. Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors. Mol Carcinog 2001;32:44-53.
13. Samarnthai N, Saikumar P, Singha P, Venkatachalam MA, Gunn SR, Yeh I. TMEPAI gene amplification in triple negative breast cancers. Mod Pathol 2010;23:70A.
14. Watanabe Y, Itoh S, Goto T, et al. TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol Cell 2010;37:123-34.
15. Kar R, Singha PK, Venkatachalam MA, Saikumar P. A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. Oncogene 2009;28:2556-68.
16. Parish CR, Jakobsen KB, Coombe DR. A basement-membrane permeability assay which correlates with the metastatic potential of tumour cells. Int J Cancer 1992;52:378-83.
17. Geng H, Lan R, Wang G, et al. Inhibition of autoregulated TGFβ signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia. Am J Pathol 2009;174:1291-308.
18. Lan R, Geng H, Hwang Y, et al. A novel wounding device suitable for quantitative biochemical analysis of wound healing and regeneration of cultured epithelium. Wound Repair Regen 2010;18:159-67.
19. Rhodes DR, Yu J, Shanker K, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 2004;101:9309-14.
20. Farina AR, Coppa A, Tiberio A, et al. Transforming growth factor-β1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer 1998;75:721-30.